Vivos Therapeutics (VVOS) Prepaid Assets (2019 - 2026)
Vivos Therapeutics' (VVOS) quarterly Prepaid Assets came in at $940000.0 in Q1 2026, up 71.85% year-on-year from $547000.0 in Q1 2025, and up 21.45% on a QoQ basis from $774000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Prepaid Assets (2019 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 8 years of Prepaid Assets data on file, last reported at $940000.0 in Q1 2026.
- On a quarterly basis, Prepaid Assets rose 71.85% year-over-year to $940000.0 in Q1 2026; TTM through Mar 2026 was $940000.0, a 71.85% increase from a year earlier, with the FY2025 full-year figure at $774000.0, down 1.15% from the prior year.
- Prepaid Assets for Q1 2026 stood at $940000.0, up from $774000.0 in the prior quarter.
- Over the last five years, Prepaid Assets for VVOS reached as high as $2.3 million in Q1 2022 and fell as low as $475000.0 in Q1 2024.
- Historically, Prepaid Assets has averaged $1.0 million across 5 years, with a median of $774000.0 in 2025.
- Across the five-year window, Prepaid Assets surged 143.09% in 2022 and sank 64.71% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $1.4 million in 2022, then sank by 57.46% to $616000.0 in 2023, then advanced by 27.11% to $783000.0 in 2024, then declined by 1.15% to $774000.0 in 2025, then advanced by 21.45% to $940000.0 in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $940000.0 in Q1 2026, $774000.0 in Q4 2025, and $565000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Vivos Therapeutics | 3.62 Mn | 1.38 Mn | 3.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 940,000.00 |
| Dec 31, 2025 | 774,000.00 |
| Sep 30, 2025 | 565,000.00 |
| Jun 30, 2025 | 695,000.00 |
| Mar 31, 2025 | 547,000.00 |
| Dec 31, 2024 | 783,000.00 |
| Sep 30, 2024 | 634,000.00 |
| Jun 30, 2024 | 554,000.00 |
| Mar 31, 2024 | 475,000.00 |
| Dec 31, 2023 | 616,000.00 |
| Sep 30, 2023 | 769,000.00 |
| Jun 30, 2023 | 1.07 Mn |
| Mar 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 1.45 Mn |
| Sep 30, 2022 | 2.12 Mn |
| Jun 30, 2022 | 2.06 Mn |
| Mar 31, 2022 | 2.26 Mn |
| Dec 31, 2021 | 1.58 Mn |
| Sep 30, 2021 | 1.60 Mn |
| Jun 30, 2021 | 1.67 Mn |